In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report), ...
Learn more about whether The Ensign Group, Inc. or Henry Schein, Inc. is a better investment based on AAII's A+ Investor ...
Shares of Henry Schein Inc. HSIC advanced 1.65% to $81.91 Wednesday, on what proved to be an all-around great trading session ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA). The company’s "first-in-class" suzetrigine pain pill ...
President Trump on Friday vowed to impose sweeping tariffs on semiconductor chips, pharmaceuticals, steel and aluminum and oil and gas. “We’ll be doing pharmaceuticals. Importantly in drugs ...
semiconductors and pharmaceuticals in a push to increase U.S. production of the products. Trump announced the moves during remarks at a congressional Republican treat at the Trump National Doral ...
The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...